BMS, Disability Solutions launch programme to boost trial diversity
DDiCT will offer recommendations on boosting access, engagement and participation of individuals with disabilities in trials.

DDiCT will offer recommendations on boosting access, engagement and participation of individuals with disabilities in trials.
Worldwide will have access to data insights based on demographics, geography, incidence and epidemiology for rare diseases.
The acquisition is expected to accelerate clinical development pathway of CYB004 by nine months.
MD Anderson researchers design and develop trials to detect best ways for cancer prevention, diagnosis and treatment.
With the takeover, underrepresented population in the Latin American region will have access to clinical trials.
Utilising SiteLink, sponsors can now connect to sites remotely for all phases and treatment areas of the trials.
Through the merger with Aventiv, Centricity now provides CROs and sponsors access to 45 clinical trial sites.
Labcorp can utilise the HealthVerity IPGE platform to align de-identified patient data with greater accuracy.
Thank you for subscribing to Clinical Trials Arena